Malcisbo is specialized on glycoengineering technologies to develop novel and efficient glycoconjugate vaccines for unmet needs in human and veterinary medicine targeting large markets. Our platform technology provides a tool to develop a strong pipeline of novel, cost-efficient vaccine products.

Location

Wagistrasse 27a, 8952 Schlieren, Switzerland

Facts & figures
  • Type of organization

    Private company

  • Year of foundation

    2010

  • Number of employees in Switzerland

    1-9

Key business